Now Foods Kava Kava 250mg 60 VC
Have you tried everything to relax and de-stress and nothing works? Try Kava Kava extract from Now Foods! This herbal relaxing blend made of 30% Kavalactones promotes relaxation and can help reduce stress through the power of the Kava Kava plant.
Now Foods Kava Kava Benefits
- Contains 30% Kavalactones
- Herbal Blend
- Promotes Relaxation
- Can Help Reduce Anxiety & Stress
How to Take Now Foods Kava Kava
Take 1 capsule one to two times daily as needed. Do not take daily for more than 4 weeks. Store in a cool, dry place after opening.
Now Foods Kava Kava Ingredients
Serving Size: 1 Veg Capsule
Servings Per Container: 60
Amount per Serving % Daily Value
* Percent Daily Values are based on 2,000 calorie diet.
† Daily Value not established.
Kava Kava Extract (Piper methysticum) (Root)
(Standardized to contain min. 30% Kavalactones) 250 mg †
(Eleutherococcus senticosus) (Root) 100 mg †
Cellulose (capsule), Cellulose Powder, Magnesium Stearate (vegetable source) and Silica.
Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish or tree nut ingredients. Produced in an GMP facility that processes other ingredients containing these allergens.
Now Foods Kava Kava Warnings & Side Effects
US FDA advises that a potential risk of rare, but severe, liver injury may be associated with kava-containing dietary supplements. Ask a healthcare professional before use if you have or have had liver problems, frequently use alcoholic beverages, or are taking any medication. Stop use and see a doctor if you develop symptoms that may signal liver problems (e.g., unexplained fatigue, abdominal pain, loss of appetite, fever, vomiting, dark urine, pale stools, yellow eyes or skin). Not for use by persons under 18 years of age, or by pregnant or breast feeding women. Not for use with alcoholic beverages. Excessive use or use with products that cause drowsiness may impair your ability to operate a vehicle or heavy equipment.
Sarris J, Stough C, Bousman CA, et al. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study. J Clin Psychopharmacol. 2013;33(5):643‐648. doi:10.1097/JCP.0b013e318291be67